452 related articles for article (PubMed ID: 35628648)
1. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation.
Gaál Z
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628648
[TBL] [Abstract][Full Text] [Related]
2. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
3. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in hematological malignancies.
Lawrie CH
Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of let-7 family in the pathogenesis of hematological malignancies.
Yazarlou F; Kadkhoda S; Ghafouri-Fard S
Biomed Pharmacother; 2021 Dec; 144():112334. PubMed ID: 34656064
[TBL] [Abstract][Full Text] [Related]
6. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.
Huang W; Paul D; Calin GA; Bayraktar R
Cells; 2023 Dec; 13(1):. PubMed ID: 38201290
[TBL] [Abstract][Full Text] [Related]
7. The functions and clinical significance of circRNAs in hematological malignancies.
Zhou X; Zhan L; Huang K; Wang X
J Hematol Oncol; 2020 Oct; 13(1):138. PubMed ID: 33069241
[TBL] [Abstract][Full Text] [Related]
8. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
Barbarotto E; Calin GA
Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
Xie L; Jing R; Qi J; Lin Z; Ju S
Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
11. Expression of non-coding RNAs in hematological malignancies.
Ghafouri-Fard S; Esmaeili M; Taheri M
Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in hematological malignancies: a novel approach to targeted therapy.
Joshi D; Gosh K; Vundinti BR
Hematology; 2012 May; 17(3):170-5. PubMed ID: 22664117
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of miRNA genes in acute leukemia.
Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.
Mian YA; Zeleznik-Le NJ
Curr Drug Targets; 2010 Jul; 11(7):801-11. PubMed ID: 20370647
[TBL] [Abstract][Full Text] [Related]
15. Aberrant microRNA expression and its implications in the pathogenesis of leukemias.
Babashah S; Sadeghizadeh M; Tavirani MR; Farivar S; Soleimani M
Cell Oncol (Dordr); 2012 Oct; 35(5):317-34. PubMed ID: 22956261
[TBL] [Abstract][Full Text] [Related]
16. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
17. miR-155 as a novel clinical target for hematological malignancies.
Witten L; Slack FJ
Carcinogenesis; 2020 Mar; 41(1):2-7. PubMed ID: 31711135
[TBL] [Abstract][Full Text] [Related]
18. MiRNA Dysregulation in Childhood Hematological Cancer.
Carvalho de Oliveira J; Molinari Roberto G; Baroni M; Bezerra Salomão K; Alejandra Pezuk J; Sol Brassesco M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201877
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes.
Ghaedi H; Bastami M; Zare-Abdollahi D; Alipoor B; Movafagh A; Mirfakhraie R; Omrani MD; Masotti A
Genomics; 2015 Dec; 106(6):360-6. PubMed ID: 26520014
[TBL] [Abstract][Full Text] [Related]
20. MiR-26a-5p as a Reference to Normalize MicroRNA qRT-PCR Levels in Plasma Exosomes of Pediatric Hematological Malignancies.
Damanti CC; Gaffo E; Lovisa F; Garbin A; Di Battista P; Gallingani I; Tosato A; Pillon M; Carraro E; Mascarin M; Elia C; Biffi A; Bortoluzzi S; Mussolin L
Cells; 2021 Jan; 10(1):. PubMed ID: 33429910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
